Between celebrity endorsements, before-and-after TikToks, and the increasing evidence of its weight-loss benefits, it is no surprise that the rapidly growing popularity of semaglutide as a weight loss tool has led to a nationwide shortage of the glucagon-like peptide 1 (GLP-1) receptor agonist
TRIUMPH-2 is testing retatrutide in adults living with type 2 diabetes, and TRIUMPH-3 is looking at heart disease outcomes
A man starts Ozempic or Mounjaro, loses 15 kilos (around 33 lb), feels transformed then reads a forum post claiming the injection will hand him a kidney stone, and the worry undoes the good
Aside from weight loss, Bilica said these medications can decrease blood pressure, cholesterol and also prevent some forms of heart disease
Is this definitively better than tirzepatide for muscle preservation